Dergiler / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 3

Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey

Sayfa
260–265
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

HCVseroprevalence was low and HIV positivity was not encountered in the study population.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: The vertical transmission of hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections are essential public health problems.
📊
Temel Bulgular & Veri:In this study, we aimed to investigate the seroprevalence of the aforementioned infectionsamong pregnant women.Materials and Methods: This study was done retrospectively on pregnant women who presented for antenatal follow-up and delivery between 2013 and 2016.
💡
Sonuç & Katkı:HCVseroprevalence was low and HIV positivity was not encountered in the study population.
🔬Tür:Araştırma Makalesi
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: The vertical transmission of hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections are essential public health problems. In this study, we aimed to investigate the seroprevalence of the aforementioned infectionsamong pregnant women.Materials and Methods: This study was done retrospectively on pregnant women who presented for antenatal follow-up and delivery between 2013 and 2016. Data were collected from the hospital’s electronic health records and patient files. Blood samples were analyzedat the microbiology laboratory of the hospital. HBsAg, anti-HBs, anti-HCV, and anti-HIV titers were tested using the chemiluminescenceenzyme immunoassay method (Architect, Abbott Laboratories, USA).Results: HBsAg and anti-HBs levels were tested in 35,295 pregnant women aged 18-45 years. The HBsAg and anti-HBs levels were positivein 425 (1.2%) and 9583 (27.7%) patients, respectively. From 2013 to 2016, the HBV carrier rates have continuously decreased from 1.4% to0.8%, whereas the anti-HBs positivity has increased from 25.4% to 30.2%. Anti-HCV was detected in 6 of the 9709 (0.06%) patients. Allthe 7113 pregnant women screened for HIV showed negative results.Conclusion: Hepatitis B carrier rates among pregnant women gradually decreased with a simultaneous increase in the immunity rates. HCVseroprevalence was low and HIV positivity was not encountered in the study population.

🔖

Bu Makaleye Atıf Yap

TANRIVERDİ, E. Ç., ÖZKURT, Z., KADIOĞLU, B. G., ALAY, H., ÇALIKOĞLU, E. O., KOCA, Ö., KAMALAK, Z. (2019). Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 3, 260–265. https://ajindex.com/articles/410030

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. World Health Organization, Global Hepatitis Report 2017. (http:// www.who.int/hepatitis/publications/global-hepatitis-report2017/ en/) accessed 06/02/2018. Dinsmoor MJ. Hepatitis in the obstetric patients. Infect Dis Clin North Am 1997; 11: 77-91. [CrossRef] Aktuğ Demir N, Asan A, Ayaz C, et al. Management of Chronic Hepatitis B in Pregnancy: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases. Klimik Journal 2013; 26(Suppl 1): 12-9. [CrossRef] Cunningham GF, Gant NF, Leveno KJ, et al. Gastrointestinal Disorders. In: Williams Obstetrics, 21st ed. New York: McGraw-Hill, 2001; pp: 1273-1306.
  2. Tosone G, Maraolo AE, Mascolo S, et al. Vertical hepatitis C virus transmission: Main questions and answers. World J Hepatol 2014; 6: 538-48. [CrossRef] Yeung CY, Lee HC, Chan WT, et al. Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J Hepatol 2014; 6: 643-51. [CrossRef] Mistik R, Balik I. Epidemiological analysis of viral hepatitis in Turkey. In: Kılıçturgay K, Badur S editors. Viral Hepatitis. İstanbul: Medikal Sağlık ve Yayıncılık, 2001; p:10-55. Wasmuth JC. HepatitisB-epidemiology, transmission and natural history. In: Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, editors. Hepatology. Dusseldorf: Flying Publisher; 2009, p: 25-36.
  3. Xiao XM, Li AZ, Chen X, et al. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007; 96: 167-70. [CrossRef] Grosheide PM, Wladimiroff JW, Heijtink RA, et al. Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. Br Med J 1995; 311: 1197. [CrossRef] Bal A, Petrova A. Single Clinical Practice’s Report of Testing Initiation, Antibody Clearance, and Transmission of Hepatitis C Virus (HCV) in Infants of Chronically HCV Infected Mothers. Open Forum Infect Dis 2016; 3: ofw021. Thomas, SL, Newell ML, Peckham CS, et al. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998; 27: 108-20. [CrossRef] Reddick KL, Jhaveri R, Gandhi M, et al. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 2011; 18: e394-8. [CrossRef] Pergam SA, Wang CC, Gardella CM, et al. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birt